Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system and has profound impacts on morbidity and mortality. There are multisystem consequences of poor cardiovascular-kidney-metabolic health, with the most significant clinical impact being the high associated incidence of cardiovascular disease events and cardiovascular mortality. There is a high prevalence of poor cardiovascular-kidney-metabolic health in the population, with a disproportionate burden seen among those with adverse social determinants of health. However, there is also a growing number of therapeutic options that favorably affect metabolic risk factors, kidney function, or both that also have cardioprotective effects. To improve cardiovascular-kidney-metabolic health and related outcomes in the population, there is a critical need for (1) more clarity on the definition of cardiovascular-kidney-metabolic syndrome; (2) an approach to cardiovascular-kidney-metabolic staging that promotes prevention across the life course; (3) prediction algorithms that include the exposures and outcomes most relevant to cardiovascular-kidney-metabolic health; and (4) strategies for the prevention and management of cardiovascular disease in relation to cardiovascular-kidney-metabolic health that reflect harmonization across major subspecialty guidelines and emerging scientific evidence. It is also critical to incorporate considerations of social determinants of health into care models for cardiovascular-kidney-metabolic syndrome and to reduce care fragmentation by facilitating approaches for patient-centered interdisciplinary care. This presidential advisory provides guidance on the definition, staging, prediction paradigms, and holistic approaches to care for patients with cardiovascular-kidney-metabolic syndrome and details a multicomponent vision for effectively and equitably enhancing cardiovascular-kidney-metabolic health in the population.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Cardiovascular Diabetology
30 publications, 3.25%
|
|
|
Diabetes, Obesity and Metabolism
22 publications, 2.39%
|
|
|
Diabetology and Metabolic Syndrome
21 publications, 2.28%
|
|
|
Circulation
19 publications, 2.06%
|
|
|
Journal of the American Heart Association
19 publications, 2.06%
|
|
|
Journal of the American College of Cardiology
19 publications, 2.06%
|
|
|
Frontiers in Endocrinology
18 publications, 1.95%
|
|
|
Frontiers in Nutrition
17 publications, 1.84%
|
|
|
American Journal of Preventive Cardiology
16 publications, 1.74%
|
|
|
Journal of Clinical Medicine
15 publications, 1.63%
|
|
|
BMC Cardiovascular Disorders
14 publications, 1.52%
|
|
|
JACC: Heart Failure
13 publications, 1.41%
|
|
|
European Journal of Preventive Cardiology
13 publications, 1.41%
|
|
|
International Journal of Molecular Sciences
12 publications, 1.3%
|
|
|
Frontiers in Cardiovascular Medicine
12 publications, 1.3%
|
|
|
Scientific Reports
12 publications, 1.3%
|
|
|
JACC Advances
11 publications, 1.19%
|
|
|
Heart Lung and Circulation
9 publications, 0.98%
|
|
|
Nephrology Dialysis Transplantation
8 publications, 0.87%
|
|
|
BMC Public Health
8 publications, 0.87%
|
|
|
Cardiology Clinics
8 publications, 0.87%
|
|
|
European Journal of Internal Medicine
7 publications, 0.76%
|
|
|
Antioxidants
7 publications, 0.76%
|
|
|
Nutrients
7 publications, 0.76%
|
|
|
Current Cardiology Reports
7 publications, 0.76%
|
|
|
JAMA Cardiology
6 publications, 0.65%
|
|
|
Clinical journal of the American Society of Nephrology : CJASN
6 publications, 0.65%
|
|
|
European Heart Journal
6 publications, 0.65%
|
|
|
Journal of the American Society of Nephrology : JASN
6 publications, 0.65%
|
|
|
5
10
15
20
25
30
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
237 publications, 25.7%
|
|
|
Springer Nature
191 publications, 20.72%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
80 publications, 8.68%
|
|
|
MDPI
70 publications, 7.59%
|
|
|
Wiley
63 publications, 6.83%
|
|
|
Frontiers Media S.A.
60 publications, 6.51%
|
|
|
Oxford University Press
50 publications, 5.42%
|
|
|
Cold Spring Harbor Laboratory
30 publications, 3.25%
|
|
|
Taylor & Francis
20 publications, 2.17%
|
|
|
American Medical Association (AMA)
15 publications, 1.63%
|
|
|
BMJ
11 publications, 1.19%
|
|
|
SAGE
8 publications, 0.87%
|
|
|
Public Library of Science (PLoS)
7 publications, 0.76%
|
|
|
The Endocrine Society
7 publications, 0.76%
|
|
|
S. Karger AG
7 publications, 0.76%
|
|
|
Silicea - Poligraf, LLC
6 publications, 0.65%
|
|
|
Massachusetts Medical Society
6 publications, 0.65%
|
|
|
Remedium, Ltd.
6 publications, 0.65%
|
|
|
Baishideng Publishing Group
5 publications, 0.54%
|
|
|
American Physiological Society
4 publications, 0.43%
|
|
|
American College of Physicians
3 publications, 0.33%
|
|
|
Medknow
3 publications, 0.33%
|
|
|
American Diabetes Association
3 publications, 0.33%
|
|
|
IMR Press
2 publications, 0.22%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 0.22%
|
|
|
Mary Ann Liebert
2 publications, 0.22%
|
|
|
IntechOpen
2 publications, 0.22%
|
|
|
SciELO
2 publications, 0.22%
|
|
|
American Society of Nephrology
1 publication, 0.11%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.11%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.